Ste14 protein, S cerevisiae

Known as: YDR410C protein, S cerevisiae, isoprenylcysteine carboxylmethyltransferase Ste14, S cerevisiae 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2016
0120112016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Pancreatic cancer remains one of the most difficult to treat human cancers despite recent advances in targeted therapy… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Isoprenylcysteine carboxylmethyltransferase (ICMT) catalyzes the post-translational modification of RAB GTPases that contain C… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2017
2017
Despite extensive effort, there has been limited progress in the development of direct RAS inhibitors. Targeting… (More)
  • figure 1
  • figure 2
Is this relevant?
2016
2016
Despite the success of BCR-ABL1 tyrosine kinase inhibitors in patients with chronic myeloid leukemia (CML), resistance to… (More)
Is this relevant?
2013
2013
Inhibition of isoprenylcysteine Carboxylmethyltransferase (ICMT) is of particular interest as a potential target for the… (More)
Is this relevant?
2011
2011
Numerous proteins involved in diverse aspects of cell biology undergo a process of post-translational modification termed… (More)
Is this relevant?